Related references
Note: Only part of the references are listed.The Heterogeneous Prognosis of Patients With Myelodysplastic Syndrome and Chromosome 5 Abnormalities How Does It Relate to the Original Lenalidomide Experience in MDS?
Hagop Kantarjian et al.
CANCER (2009)
Many are called MDS cell lines: One is chosen
Hans G. Drexler et al.
LEUKEMIA RESEARCH (2009)
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide
Sheng Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing
Claudia Haferlach et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Characterization of centrosomal localization and dynamics of Cdc25C phosphatase in mitosis
Jerome Bonnet et al.
CELL CYCLE (2008)
DNA ploidy and cell cycle analyses in the bone marrow cells of patients with megaloblastic anemia using laser scanning cytometry
Takayuki Tsujioka et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2008)
Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan
T. Tasaka et al.
LEUKEMIA (2008)
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Benjamin L. Ebert et al.
NATURE (2008)
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1-risk myelodysplastic syndromes with karyotypes other than deletion 5q
Azra Raza et al.
BLOOD (2008)
Limiting the proliferation of polyploid cells
Neil J. Ganem et al.
CELL (2007)
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders
John M. Joslin et al.
BLOOD (2007)
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients
Andrea Pellagatti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation
Ting Xi Liu et al.
NATURE MEDICINE (2007)
Origins and consequences of centrosome aberrations in human cancers
Erich A. Nigg
INTERNATIONAL JOURNAL OF CANCER (2006)
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Alan List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Lenalidomide inhibits proliferation of Namalwa CSN.70 cells and interferes with Gab1 phosphorylation and adaptor protein complex assembly
AK Gandhi et al.
LEUKEMIA RESEARCH (2006)
Protein-tyrosine kinase Syk is required for pathogen engulfment in complement-mediated phagocytosis
Yuhong Shi et al.
BLOOD (2006)
Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup
AAN Giagounidis et al.
ANNALS OF HEMATOLOGY (2005)
Phosphorylation of ZEN-4/MKLP1 by aurora B regulates completion of cytokinesis
A Guse et al.
CURRENT BIOLOGY (2005)
The molecular requirements for cytokinesis
M Glotzer
SCIENCE (2005)
Relocation of Aurora B from centromeres to the central spindle at the metaphase to anaphase transition requires MKIp2
U Gruneberg et al.
JOURNAL OF CELL BIOLOGY (2004)
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31
AAN Giagounidis et al.
LEUKEMIA (2004)
Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs
PH Schafer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
K Dredge et al.
BRITISH JOURNAL OF CANCER (2002)
Disruption of centrosome structure, chromosome segregation, and cytokinesis by misexpression of human Cdc14A phosphatase
BK Kaiser et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome
J Boultwood et al.
BLOOD (2002)
The cytogenetics of myelodysplastic syndromes
HJ Olney et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2001)
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
FE Davies et al.
BLOOD (2001)
Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1
PR Andreassen et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
The human kinesin-like protein RB6K is under tight cell cycle control and is essential for cytokinesis
RD Fontijn et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF
S Nakamura et al.
CYTOKINES CELLULAR & MOLECULAR THERAPY (2000)
Share Paper
